Kumano K, Khairallah P A
J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):756-61. doi: 10.1097/00005344-198409000-00004.
Adrenergic receptor response coupling pathways have been shown to differ in hypertrophied hearts in different models of hypertension. To mimic this, chronic subcutaneous infusions of epinephrine (80 nmol/h for up to 13 days) and angiotensin II (AII) (4.3 nmol/h for up to 4 weeks) were given. Myocardial-, basal-, and isoproterenol-, glucagon-, forskolin-, and Gpp(NH)p-stimulated adenylate cyclase were measured. No changes in enzyme activity were seen following AII infusion, even though myocardial hypertrophy was significant. After epinephrine infusion for 6 days, there was a decrease in isoproterenol stimulated enzyme. After 13 days of infusion, cyclase activity, both basal and stimulated, was reduced. We conclude that in hearts from different models of experimental hypertension associated with cardiac hypertrophy, there are different biochemical alterations in the beta-adrenergic receptor response coupling mechanism.
在不同的高血压模型中,已证明肾上腺素能受体反应偶联途径在肥厚心脏中存在差异。为模拟这种情况,给予慢性皮下输注肾上腺素(80 nmol/h,持续长达13天)和血管紧张素II(AII)(4.3 nmol/h,持续长达4周)。测量了心肌、基础、异丙肾上腺素、胰高血糖素、福斯高林和Gpp(NH)p刺激的腺苷酸环化酶。尽管心肌肥厚显著,但输注AII后未观察到酶活性变化。肾上腺素输注6天后,异丙肾上腺素刺激的酶活性降低。输注13天后,基础和刺激的环化酶活性均降低。我们得出结论,在与心脏肥厚相关的不同实验性高血压模型的心脏中,β-肾上腺素能受体反应偶联机制存在不同的生化改变。